Could you please provide the numbers of patients treated in the last 3 months by the Gastroenterology department for any medical condition, and if possible, for Ulcerative Colitis, with the following biologic drugs:
1. Total Gastroenterology Patients
2. Ulcerative Colitis Patients
a. Adalimumab – Humira
b. Adalimumab Biosimilar
c. Filgotinib
d. Golimumab
e. Infliximab – Remicade
f. Infliximab Biosimilar
g. Ozanimod
h. Tofacitinib
i. Ustekinumab
j. Vedolizumab
Biologic drugs in Gastroenterology.140322.docx
